Phibro Animal Health | PAHC - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Align Technology USD 1.91B 4.9M 2026-09
ANI Pharmaceuticals USD 328.72M 45.06M 2026-09
Aurora Cannabis CAD 73.43M 6.5M 2026-06
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Canopy Growth CAD 166.75M 8.31M 2026-06
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Eli Lilly USD 47B 745M 2026-09
Henry Schein USD 3.6B 110M 2026-09
Idexx Laboratories USD 1.26B 23.44M 2026-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Merck USD 28.8B 1.07B 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Pacira USD 126.1M 4.08M 2026-09
Phibro Animal Health USD 295.79M 20.68M 2026-09
Prestige Brands USD 168.5M 14.7M 2026-09
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
Zoetis USD 2.68B 621M 2026-09